Method and device for the quantitative libs measurement of bio-molecular targets on a biochip
US-2015233837-A1 · Aug 20, 2015 · US
US10514338B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10514338-B2 |
| Application number | US-201615042969-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 12, 2016 |
| Priority date | Sep 12, 2014 |
| Publication date | Dec 24, 2019 |
| Grant date | Dec 24, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A target within a sample can be characterized using an energy source configured to transform a metal in the sample into a plasma and an optical spectroscopic detector configured to detect electromagnetic radiation emitted by the plasma to provide an optical-spectrum signal. A processor can determine presence of the metal in the sample using the optical-spectrum signal. The target can include a microbe or biological toxin. A recognition construct comprising a metal and a scaffold can be applied to the sample. The scaffold can bind to the target. Energy can be applied to transform at least some of the sample into a plasma. Electromagnetic radiation emitted by the plasma can be detected to provide an optical-spectrum signal of the sample. A preparation subsystem can add the recognition construct to the sample and a washing subsystem can wash unbound recognition construct out of the sample.
Opening claim text (preview).
The invention claimed is: 1. A system for characterizing a target within a sample, the system comprising: a substrate configured to retain the sample, the substrate comprising a silicon surface and a capture antibody coupled to the silicon surface, the capture antibody being configured to attach to the target; the sample comprising a biomolecular recognition construct, wherein the biomolecular recognition construct comprises: a scaffold configured to couple with the target; a polymer coupled to the scaffold and comprising a metal-chelating ligand; and a first metal atom or ion linked to the metal-chelating ligand; an energy source configured to transform the first metal atom or ion in the sample into a plasma; an optical spectroscopic detector configured to detect electromagnetic radiation emitted by the plasma and to provide an optical-spectrum signal of the sample based at least in part on at least some of the electromagnetic radiation; a processor; and a memory storing instructions executable by the processor to cause the processor to perform operations comprising: generating a normalized optical-spectrum signal by normalizing the optical-spectrum signal of the sample with respect to an optical-spectrum signal of a material of the substrate; and determining presence of the first metal atom or ion in the sample based at least in part on the normalized optical-spectrum signal. 2. The system according to claim 1 , the operations further comprising: performing spectral unmixing on the optical-spectrum signal of the sample; performing constrained energy minimization on the optical-spectrum signal of the sample; or determining presence of the metal atom or ion in the sample by applying the optical-spectrum signal of the sample to a multi-class classifier selected from the group consisting of a support vector machine, a kernel estimator, a nearest-neighbor classifier, a decision tree, a decision forest, a neural network, or a deep neural network. 3. The system according to claim 1 , the operations further comprising: determining presence of a second metal atom or ion in the sample based at least in part on the optical-spectrum signal of the sample, wherein: the first metal atom or ion is an atom or ion of a first element; and the second metal atom or ion is an atom or ion of a second element different from the first element. 4. The system according to claim 1 , wherein the substrate comprises a silicon wafer. 5. The system according to claim 1 , wherein the substrate comprises recognition macromolecules that comprise the capture antibody. 6. The system according to claim 1 , wherein the scaffold comprises at least one of: adNectin, iMab, anticalin, designed ankyrin repeat protein (DARPin), affilin, tetranectin, or avimer. 7. The system according to claim 1 , wherein the biomolecular recognition construct consists essentially of: the scaffold; the polymer; and the first metal atom or ion bound to the metal-chelating ligand. 8. The system according to claim 7 , wherein the scaffold consists essentially of a structure selected from the group consisting of adNectin, iMab, anticalin, designed ankyrin repeat protein (DARPin), affilin, tetranectin, and avimer. 9. The system according to claim 1 , wherein the biomolecular recognition construct comprises: at least one scaffold, the at least one scaffold comprising the scaffold; one or more polymers, the one or more polymers comprising the polymer; and one or more metal atoms or ions, each of the one or more metal atoms or ions bound to a respective metal-chelating ligand of a corresponding polymer of the one or more polymers, wherein the one or more metal atoms or ions comprise the first metal atom or ion, and the metal-chelating ligand is one of the respective metal-chelating ligands. 10. The system according to claim 9 , wherein the scaffold consists of a structure selected from the group consisting of adNectin, iMab, anticalin, designed ankyrin repeat protein (DARPin), affilin, tetranectin, and avimer. 11. The system according to claim 1 , wherein the metal-chelating ligand comprises diethyl enetriaminepenta-acetic acid (DTPA), wherein the first metal atom or ion linked to the metal-chelating ligand comprises a lanthanide. 12. The system according to claim 1 , wherein the capture antibody is an antitoxin antibody. 13. The system according to claim 1 , wherein generating the normalized optical-spectrum signal comprises normalizing the optical-spectrum signal of the sample with respect to an optical-spectrum signal of silicon.
using electric arcs or discharges · CPC title
Laser microanalysis, i.e. with formation of sample plasma · CPC title
involving labelled substances (G01N33/53 takes precedence) · CPC title
Bacteria · CPC title
Immunoassays for the detection of microorganisms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.